Treatment of epiretinal membrane: An update

Hong Kong Medical Journal

Volumn 11, Issue 6, 2005, Pages 496-502

  Ting, F S M ^a   Kwok, A K H ^a  

^a HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Epiretinal membrane; Indocyanine green; Treatment outcome; Vitrectomy

Indexed keywords

DYE; INDOCYANINE GREEN; TRYPAN BLUE;

EVALUATION; HUMAN; RETINA INJURY; REVIEW; SAFETY; STAINING; TECHNIQUE; VISION; VITRECTOMY;

AGING; COLORING AGENTS; EPIRETINAL MEMBRANE; HONG KONG; HUMANS; INDOCYANINE GREEN; POSTOPERATIVE COMPLICATIONS; TRYPAN BLUE; VISUAL ACUITY; VITRECTOMY;

EID: 30944438864     PISSN: 10242708     EISSN: 10242708     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 1997;104:1033-40.
2. Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 2003;110:34-40.
3. Miller B. Epiretinal macular membranes: pathogenesis and treatment. Dev Ophthalmol 1997;29:61-3.
4. Appiah AP, Hirose T, Kado M. A review of 324 cases of idiopathic premacular gliosis. Am J Ophthalmol 1988;106:533-5.
5. Tadayoni R, Paques M, Massin P, Mouki-Benani S, Mikol J, Gaudric A. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology 2001;108:2279-83.
6. Kwok AK, Lai TY, Yew DT, Li WW. Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol 2003;136:223-30.
7. Suzuki T, Terasaki H, Niwa T, Mori M, Kondo M, Miyake Y. Optical coherence tomography and focal macular electro-retinogram in eyes with epiretinal membrane and macular pseudohole. Am J Ophthalmol 2003;136:62-7.
8. Matsumoto C, Arimura E, Okuyama S, Takada S, Hashimoto S, Shimomura Y. Quantification of metamorphopsia in patients with epiretinal membranes. Invest Ophthamlol Vis Sci 2003;44:4012-6.
9. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-8.
10. Kwok AK, Li WW, Pang CP, et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 2001;132:178-83.
11. Kwok AK, Lai TY, Chan WM, Woo DC. Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 2003;87:71-4.
12. Kwok AK, Lai TY, Yuen KS, Tam BS, Wong VW. Macular hole surgery with or without indocyanine green stained internal limiting membrane peeling. Clin Experiment Ophthalmol 2003;31:470-5.
13. Kwok AK, Lai TY. Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study. Br J Ophthalmol 2003;87:885-9.
14. Kusaka S, Hayashi N, Ohji M, Hayashi A, Kamei M, Tano Y. Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalml 2001;131:388-90.
15. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stalmans P. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-4.
16. Kwok AK, Lai TY, Li WW, Yew DT, Wong VW. Trypan blue- and indocyanine green-assisted epiretinal membrane surgery: clinical and histopathological studies. Eye 2004;18:882-8.
17. Perrier M, Sebag M. Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol 2003;135:909-11.
18. Teba FA, Mohr A, Eckardt C, et al. Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003;110:2409-12.
19. Demetriades AM, Gottsch JD, Thomsen R, et al. Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology. Am J Ophthalmol 2003;135:291-6.
20. Saito Y, Lewis JM, Park I, et al. Nonvitrectomizing vitreous surgery: a strategy to prevent postoperative nuclear sclerosis. Ophthalmology 1999;106:1541-5.
21. Charles S. Techniques and tools for dissection of epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 2003;241:347-52.
22. Sakamoto H, Yamanaka I, Kubota T, Ishibashi T. Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 2003;241:204-7.
23. Yam HF, Kwok AK, Chan KP, et al. Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2003;44:370-7.
24. Kwok AK, Lai TY, Yeung CK, Yeung YS, Li WW, Chiang SW. The effects of indocyanine green and endoillumination on rabbit retina: an electroretinographic and histological study. Br J Ophthalmol 2005;89:897-900.
25. Sivalingam A, Eagle RC Jr, Duker JS, et al. Visual prognosis correlated with the presence of internal-limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery. Ophthalmology 1990;97:1549-52.
26. Mittleman D, Green WR, Michels RG, de la Cruz Z. Clinicopathologic correlation of an eye after surgical removal of an epiretinal membrane. Retina 1989;9:143-7.
27. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 2003;135:328-37.
28. Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y. Retention of dye after indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2003;136:172-4.
29. Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 2002;240:209-13.
30. Gandorfer A, Haritoglou C, Gandorfer A, Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003;44:316-23.
31. Stalmans P, Van Aken EH, Veckeneer M, Feron EJ, Stalmans I. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2002;134:282-5.
32. Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 2003;110:62-4.
33. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting membrane peeling. Clin Experiment Ophthalmol 2005;33:379-85.
34. Kwok AK, Lai TY, Li WW, Woo DC, Chan NR. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol 2004;138:194-9.
35. Ullern M, Roman S, Dhalluin JF, et al. Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study [in French]. J Fr Ophthalmol 2002;25:915-20.
36. Stalmans P, Van Aken EH, Melles G, Veckeneer M, Feron EJ, Stalmans I. Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol 2003;135:234-6.
37. Veckeneer M, van Overdam K, Monzer J, et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239:698-704.
38. Stalmans P, Feron EJ, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Veckeneer M. Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br J Ophthalmol 2003;87:713-6.
39. Donati G, Kapetanios AD, Pournaras CJ. Complications of surgery for epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 1998;236:739-46.
40. Pesin SR, Olk RJ, Grand MG, et al. Vitrectomy for premacular fibroplasia. Prognostic factors, long-term follow-up, and time course of visual improvement. Ophthalmology 1991;98:1109-14.
41. Margherio RR, Cox MS Jr, Trese MT, Murphy PL, Johnson J, Minor LA. Removal of epimacular membranes. Ophthalmology 1985;92:1075-83.
42. Grewing R, Mester U. Results of surgery for epiretinal membranes and their recurrences. Br J Ophthalmol 1996;80:323-6.
43. Banach MJ, Hassan TS, Cox MS, et al. Clinical course and surgical treatment of macular epiretinal membranes in young subjects. Ophthalmology 2001;108:23-6.
44. Kim CY, Lee JH, Lee SJ, Koh HJ, Lee SC, Kwon OW. Visual field defect caused by nerve fiber layer damage associated with an internal limiting lamina defect after uneventful epiretinal membrane surgery. Am J Ophthalmol 2002;133:569-71.
45. McDonald HR, Verre WP, Aaberg TM. Surgical management of idiopathic epiretinal membranes. Ophthalmology 1986;93:978-83.
46. Rice TA, De Bustros S, Michels RG, Thompson JT, Debanne SM, Rowland DY. Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology 1986;93:602-10.
47. Scott IU, Smiddy WE, Feuer W, Merikansky A. Vitreoretinal surgery outcomes: results of a patient satisfaction/functional status survey. Ophthalmology 1998;105:795-803.